232 filings
Page 3 of 12
8-K
of7lbag88a1gcup45
23 Mar 21
Other Events
8:21am
8-K
dm8zq20r 5c8x
11 Mar 21
Hepion Pharmaceuticals to Present on CRV431 and AI-POWR™ at NASH-TAG 2021
8:38am
8-K
n4566h3psn7xl
17 Feb 21
Hepion Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
8:06am
8-K
g19umjk3vp7midr8c
10 Feb 21
Hepion Pharmaceuticals to Participate in BIO CEO & Investor Digital Conference
9:03am
8-K
b6k9xmj u6gee3u
28 Jan 21
A BETTER APPROACH TO DRUG DEVELOPMENT FOR LIVER DISEASES JANUARY 202 1 | INVESTOR PRESENTATION smart drug smart technology smart development
4:30pm
8-K
zcbknjc0k
5 Jan 21
Hepion Pharmaceuticals to Participate in Upcoming January Virtual Investor Conferences
9:36am
8-K
o1sa1pk785m8v hac
29 Dec 20
Other Events
4:24pm
8-K
lc0xubg6
22 Dec 20
Hepion Pharmaceuticals Announces FDA Clearance of IND Application for CRV431 for COVID-19
8:34am
8-K
r0df20je
10 Dec 20
Hepion Pharmaceuticals Completes 75 mg CRV431 Dosing, Initiates 225 mg Dosing in Phase 2a 'AMBITION' Clinical Trial for NASH
11:32am
8-K
7v3tsrrj
2 Dec 20
Other Events
8:12am
8-K
0z42u8ztjo c7
27 Nov 20
Hepion Pharmaceuticals Prices Public Offering
1:48pm
8-K
9kcmrqvqgtksrmpnnqjl
20 Nov 20
Termination of a Material Definitive Agreement
4:05pm
8-K
kwvn44w491bcc
18 Nov 20
Hepion Pharmaceuticals Data Safety Monitoring Board Recommends Continuation of Phase 2a 'AMBITION' Clinical Trial for Treatment of Advanced NASH
8:29am
8-K
pt45l78n
17 Nov 20
Hepion Pharmaceuticals to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium
4:53pm
8-K
q3yag
12 Nov 20
Hepion Pharmaceuticals to Present at The Liver Meeting Digital ExperienceTM 2020
9:33am
8-K
2enlv5 3jsp
10 Nov 20
Hepion Pharmaceuticals Completes First Cohort Enrollment in Phase 2a 'AMBITION' Clinical Trial
10:33am
8-K
7ad 4mjmuvn
27 Oct 20
Other Events
9:45am
8-K
8mmpg367s zisxvmm7n
5 Oct 20
Announces Creation of Clinical Pharmacology Analytics Team
9:06am
8-K
vqw9f8dw3u0g jfgut
1 Oct 20
Regulation FD Disclosure
4:27pm
8-K
b9el 6unvq
29 Sep 20
Hepion Pharmaceuticals to Present at H.C. Wainwright's 4th Annual NASH Virtual Investor Conference
8:47am